Drug company Lupin on Monday announced the launch of its digital asthma educator platform to guide patients on the correct technique of using inhalers.
This new platform is the latest initiative under Lupin’s long-running umbrella programme under the Joint Airways Initiative (JAI), for patients suffering from respiratory illnesses. Lupin has launched its digital asthma educator platform.
The platform helps and guides the asthma patients on how to use the correct technique of using inhalers, said the company in a regulatory filing.
— Lupin (@LupinGlobal) June 7, 2021
Rajeev Sibal, President – India Region Formulations, Lupin said, “Studies indicate that nearly 90 per cent of patients don’t use their inhalers correctly. This can have multiple implications such as developing uncontrolled symptoms, a higher rate of asthma attacks or even flare-ups. We believe this platform would assist healthcare professionals in significantly helping their patients understand correct inhalation technique and better manage their ailment.”
According to Lupin, India has nearly 35 million people living with asthma, including children and there is no cure for asthma, while it is manageable with proper treatments, vigilance, regular medical checks, and drug adherence, thus helping the patients to lead a normal life, said the company.
Lupin said it will undertake a pan India integrated marketing campaign including social media and radio channels